UBS Initiates Coverage On Chemed with Buy Rating, Announces Price Target of $650

Benzinga · 3d ago
UBS analyst A.J. Rice initiates coverage on Chemed (NYSE:CHE) with a Buy rating and announces Price Target of $650.